Anti-EV71 Capsid protein VP1/2/3 Antibody (SAA2028)

Catalog No.

RVV20304

Species reactivity

Human enterovirus 71 (strain 7423/MS/87) (EV71) (EV-71)

Host species

Human

Isotype

IgG1

Clonality

Monoclonal

Target

Genome polyprotein, P1, Capsid protein VP2, P1B, Virion protein 2, Capsid protein VP3, P1C, Virion protein 3, Capsid protein VP1, P1D, Virion protein 1

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q66479

Applications

FCM, IP, Neutralization

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

SAA2028

Immunogenicity and immunodominant linear B-cell epitopes of a new DNA-based tetravalent vaccine against four major enteroviruses causing hand, foot, and mouth disease., PMID:38705805

Variant enterovirus A71 found in immune-suppressed patient binds to heparan sulfate and exhibits neurotropism in B-cell-depleted mice., PMID:37058406

[Preparation of monoclonal antibody against enterovirus 71 capsid protein VP1]., PMID:35365993

Human Antibodies to VP4 Inhibit Replication of Enteroviruses Across Subgenotypes and Serotypes, and Enhance Host Innate Immunity., PMID:33101238

Neutrophil extracellular traps induced by VP1 contribute to pulmonary edema during EV71 infection., PMID:31285854

Analysis of an Imported Subgenotype C2 Strain of Human Enterovirus 71 in Beijing, China, 2015., PMID:30323801

[Preparation of mouse monoclonal antibodies against EV71 capsid protein VP1]., PMID:30043737

VP1 Amino Acid Residue 145 of Enterovirus 71 Is a Key Residue for Its Receptor Attachment and Resistance to Neutralizing Antibody during Cynomolgus Monkey Infection., PMID:29848582

Non-neutralizing Antibody Responses against VP1 in Enterovirus A, B, C and Rhinovirus A species among Infants and Children in Shanghai., PMID:29615683

Identification and production of mouse scFv to specific epitope of enterovirus-71 virion protein-2 (VP2)., PMID:29356992

Poorly neutralizing polyclonal antibody in vitro against coxsackievirus A16 circulating strains can prevent a lethal challenge in vivo., PMID:29337652

Specific Unbinding Forces Between Mutated Human P-Selectin Glycoprotein Ligand-1 and Viral Protein-1 Measured Using Force Spectroscopy., PMID:29016136

[Preparation of monoclonal antibodies against enterovirus type 71 with an epitope-incorporated adenovirus type 3 vector]., PMID:27412945

Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges., PMID:27373596

Enterovirus 71 transmission by exosomes establishes a productive infection in human neuroblastoma cells., PMID:26837894

Protein microarray-mediated detection of antienterovirus antibodies in serum., PMID:26831405

EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge., PMID:26809443

Pros and cons of VP1-specific maternal IgG for the protection of Enterovirus 71 infection., PMID:26529069

Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral Entry., PMID:26401034

Development of a Specific Latex Agglutination Test to Detect Antibodies of Enterovirus 71., PMID:26363276

A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71., PMID:26243660

Monoclonal neutralizing antibodies against EV71 screened from mice immunized with yeast-produced virus-like particles., PMID:26040893

Determinants of EV71 immunogenicity and protection against lethal challenge in a mouse model., PMID:26025091

Characterization of the antibody response against EV71 capsid proteins in Chinese individuals by NEIBM-ELISA., PMID:26023863

Generation and characterization of a protective mouse monoclonal antibody against human enterovirus 71., PMID:25967656

Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease., PMID:25855976

GITRL as a genetic adjuvant enhances enterovirus 71 VP1 DNA vaccine immunogenicity., PMID:25772201

Cell surface nucleolin facilitates enterovirus 71 binding and infection., PMID:25673703

[Enterotoxigenic Escherichia coli heat-labile enterotoxin B subunit can efficiently induce and enhance the mucosal immune response to enterovirus 71]., PMID:25481175

[Effects of pH on the properties of colloidal gold labeling monoclonal antibody]., PMID:25374082

Identification of specific antigenic epitope at N-terminal segment of enterovirus 71 (EV-71) VP1 protein and characterization of its use in recombinant form for early diagnosis of EV-71 infection., PMID:24952304

Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge., PMID:24885121

Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in mice., PMID:24885030

A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved "knob" region of VP3 protein., PMID:24875055

Expression of enterovirus 71 capsid protein VP1 in Escherichia coli and its clinical application., PMID:24688514

Monoclonal antibodies for diagnosis of enterovirus 71., PMID:24328741

Enterovirus 71 VP1 activates calmodulin-dependent protein kinase II and results in the rearrangement of vimentin in human astrocyte cells., PMID:24073199

Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice., PMID:23936115

Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction., PMID:23935488

VP2 dominated CD4+ T cell responses against enterovirus 71 and cross-reactivity against coxsackievirus A16 and polioviruses in a healthy population., PMID:23863902

Immunological and biochemical characterization of coxsackie virus A16 viral particles., PMID:23226233

Characterization of a novel monoclonal antibody reactive against the N-terminal region of Enterovirus 71 VP1 capsid protein., PMID:23219932

Recombinant VP1 protein expressed in Pichia pastoris induces protective immune responses against EV71 in mice., PMID:23159634

Characterization of enterovirus 71 capsids using subunit protein-specific polyclonal antibodies., PMID:23046991

Immunological evaluation and comparison of different EV71 vaccine candidates., PMID:23008736

Identification and characterization of a monoclonal antibody recognizing the linear epitope RVADVI on VP1 protein of enterovirus 71., PMID:22930511

Immunization with recombinant enterovirus 71 viral capsid protein 1 fragment stimulated antibody responses in hamsters., PMID:22877087

Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon., PMID:22848478

Display of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice., PMID:22728446

Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1., PMID:22691220

Document Download

Anti-EV71 Capsid protein VP1/2/3 Antibody (SAA2028).pdf